product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
IGFBP-2 Antibody
catalog :
3922S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human
application :
western blot, immunohistochemistry, immunoprecipitation, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 1
Published Application/Species/DilutionReference
  • western blot; human; 1:1000; fig 5
  • immunohistochemistry; human; 1:200; fig 3
Pickard A, McDade S, McFarland M, McCluggage W, Wheeler C, McCance D. HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures. PLoS Pathog. 2015;11:e1004988 pubmed publisher
product information
SKU :
3922S
Product-Name :
IGFBP-2 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Metabolism
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
35
Host :
Rabbit
Target :
IGFBP-2
Primary-Protein :
IGFBP2
Alt-Names :
BP2,IBP-2,IBP2,IGF-BP53,IGF-binding protein 2,IGFBP-2,IGFBP2,Insulin-like growth factor-binding protein 2,insulin-like growth factor binding protein 2, 36kDa
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.